Spelman, T. Et Al. 2017. Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice. MULTIPLE SCLEROSIS JOURNAL , vol.23, no.10 , 1346-1357.

Spelman, T., Meyniel, C., Ignacio Rojas, J., Lugaresi, A., Izquierdo, G., Grand'Maison, F., ... BOZ, C.(2017). Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice. MULTIPLE SCLEROSIS JOURNAL , vol.23, no.10, 1346-1357.

Spelman, Tim Et Al. "Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice," MULTIPLE SCLEROSIS JOURNAL , vol.23, no.10, 1346-1357, 2017

Spelman, Tim Et Al. "Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice." MULTIPLE SCLEROSIS JOURNAL , vol.23, no.10, pp.1346-1357, 2017

Spelman, T. Et Al. (2017) . "Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice." MULTIPLE SCLEROSIS JOURNAL , vol.23, no.10, pp.1346-1357.

@article{article, author={Tim Spelman Et Al. }, title={Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice}, journal={MULTIPLE SCLEROSIS JOURNAL}, year=2017, pages={1346-1357} }